Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Alliance Global Partners analyst Ben Haynor downgrades T2 Biosystems (NASDAQ:TTOO) from Buy to Neutral.

Movers
News

What’s Going On With Lucid Stock Thursday?

By Ryan Gustafson

August 3, 4:30 PM

Lucid Group, Inc. (NASDAQ: LCID) shares have been volatile on Thursday. The company is set to report its second-quarter earnings on Aug. 7.

LCID

FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects

By Nina Zdinjak

November 3, 9:24 AM

Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50

JAZZ

Raymond James Maintains Outperform on PTC Therapeutics, Raises Price Target to $60

By Benzinga Newsdesk

August 11, 5:37 AM

Raymond James analyst Danielle Brill maintains PTC Therapeutics (NASDAQ:PTCT) with a Outperform and raises the price target from $55 to $60.

PTCT

Tesla Stock May Need To Recharge: Analyst Says Elon Musk-Led Company Faces 25% Hit On Earnings

By Adam Eckert

January 10, 5:14 PM

Loup Funds' Gene Munster has his sights set on some short-term speed bumps that could impact Tesla Inc (NASDAQ: TSLA) stock over the

TSLA

Alliance Global Partners Downgrades T2 Biosystems to Neutral

Related Posts

What’s Going On With Lucid Stock Thursday?

FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects

Raymond James Maintains Outperform on PTC Therapeutics, Raises Price Target to $60

Tesla Stock May Need To Recharge: Analyst Says Elon Musk-Led Company Faces 25% Hit On Earnings